|
|
|
Volumn 18, Issue 13 Suppl 7, 2004, Pages 15-23
|
|
Use of newer antifungal therapies in clinical practice: what do the data tell us?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMPHOTERICIN B;
AMPHOTERICIN B DEOXYCHOLATE;
AMPHOTERICIN B LIPID COMPLEX;
AMPHOTERICIN B-DEOXYCHOLATE;
ANTIFUNGAL AGENT;
CASPOFUNGIN;
CYCLOPEPTIDE;
DEOXYCHOLIC ACID;
LIPOSOME;
PHOSPHATIDYLCHOLINE;
PHOSPHATIDYLGLYCEROL;
PYRIMIDINE DERIVATIVE;
TRIAZOLE DERIVATIVE;
VORICONAZOLE;
ANTIBIOTIC RESISTANCE;
ASPERGILLOSIS;
CANDIDIASIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DOSE RESPONSE;
DRUG ADMINISTRATION;
DRUG COMBINATION;
HUMAN;
MUCORMYCOSIS;
MYCOSIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
TIME;
TREATMENT OUTCOME;
AMPHOTERICIN B;
ANTIFUNGAL AGENTS;
ASPERGILLOSIS;
CANDIDIASIS;
DEOXYCHOLIC ACID;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
DRUG COMBINATIONS;
DRUG RESISTANCE, FUNGAL;
HUMANS;
LIPOSOMES;
MYCOSES;
PEPTIDES, CYCLIC;
PHOSPHATIDYLCHOLINES;
PHOSPHATIDYLGLYCEROLS;
PYRIMIDINES;
RANDOMIZED CONTROLLED TRIALS;
TIME FACTORS;
TREATMENT OUTCOME;
TRIAZOLES;
ZYGOMYCOSIS;
|
|
EID: 13944253698
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (18)
|
|
References (63)
|
